Tottenham‘s Chioma Ubogagu is serving a nine-month suspension for failing a doping take a look at after medicine for a pores and skin situation contained a prohibited substance.
Ubogagu, who scored on her England debut in 2018, joined Ladies’s Tremendous League group Tottenham final 12 months. She was initially provisionally suspended in January however particulars of the case and verdict had been introduced solely on Thursday.
Canrenone, a masking agent, was detected in an out-of-competition take a look at in October. It was in anti-acne tablets that Ubogagu had been prescribed by her dermatologist in Texas the place she performed for the Houston Sprint in 2018.
Former USWNT goalkeeper Hope Solo acquired a public warning on Monday from the U.S. Anti-Doping Company after she examined optimistic for the banned substance Canrenone in a urine take a look at. In 2012, Solo additionally acquired solely a public warning from the USADA after Canrenone was detected in her urine take a look at.
An English Soccer Affiliation regulatory fee discovered there have been no intentional doping rule breaches by Ubogagu to enhance performances and that she was taking the medicine for a recognised situation.
“I wish to clarify that the medicine had no performance-enhancing results for me, however I nonetheless made the error of not being as diligent as potential, and because of this I’m unable to play the sport I really like till I serve my suspension,” Ubogagu mentioned in an announcement. “Whereas my dermatologist is conscious of my career, it’s also my duty to know extra concerning the medicines I’m prescribed.”
See also Raiola offended amid false reporting of demise
Ubogagu can’t play once more till October.